Liminal BioSciences to Report Fourth Quarter and Year Ended 2022 Financial Results on March 15, 2023
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Liminal BioSciences Inc. (Nasdaq: LMNL) announced that it will report its fourth quarter and year-end 2022 financial results on March 15, 2023, after market close. A conference call is scheduled for 8:30 am ET on March 16, 2023 to discuss the results. Liminal is focused on developing novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases, with a lead program, LMNL6511, targeting the GPR84 receptor. The company operates in Canada and the United Kingdom.
Positive
- Upcoming financial results announcement on March 15, 2023.
- Scheduled conference call for detailed discussion on March 16, 2023.
- Ongoing development of lead program LMNL6511.
Negative
- None.
Details
News Market Reaction – LMNL
The recorded move for LMNL in the trading session of this news was -2.99%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
To join the conference call without operator assistance, you may register and enter your phone number at https://bit.ly/3FeNJBk to receive an instant automated call back. You can also dial direct to be entered to the call by an Operator by dialing 416-764-8609 and 888-390-0605, using the following passcode: 77593817. An audio replay of the call will be available as of
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words "anticipate," "expect," "suggest," "plan," "believe," "intend," "estimate," "target," "project," "should," "could," "would," "may," "will," "forecast" and other similar expressions are intended to identify forward-looking statements. These statements include those related to
View original content to download multimedia:https://www.prnewswire.com/news-releases/liminal-biosciences-to-report-fourth-quarter-and-year-ended-2022-financial-results-on-march-15-2023-301770623.html
SOURCE
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.